The report was uncontrolled, unblinded, not randomized, had no comparator arm, used patient-reported outcomes rather than validated pain instruments, and did not publish dose, effect size, confidence intervals, p-values, or systematically collected adverse events limitations that severely constrain any clinical inference
Peptides are a tool that can help with those goals
Most researchers aim for 500-1000mcg of BPC-157 and 500-1000mcg of TB-500 daily during active protocols
So, over time, that impact weakens your bone
Researchers should avoid direct contact with the eyes and skin and should use protective equipment appropriate to their institutional risk assessment